For development of the revolutionary CRISPR-Cas9 gene editing technology, with widespread applications in agriculture and health research. Feng Zhang’s innovations are fundamentally transforming our collective health and well-being and have contributed to the development of treatments for sickle cell disease, cancer, type 1 diabetes, and more.